Lv41
540 积分 2022-02-06 加入
Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC
4小时前
已完结
STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy
13天前
已完结
A metabolic atlas of mouse aging
21天前
已完结
Advances in Systemic Treatment of Breast Cancer
22天前
已完结
Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic
2个月前
已完结
Insights from the ESMO Targeted Anticancer Therapies Asia Congress 2026
2个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
2个月前
已完结
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model forBRCACarriers
3个月前
已完结
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial
4个月前
已完结
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
4个月前
已完结
皖公网安备34019202002308
